1.6800
20-February-25 13:09:55
15 minutes delayed
Stocks
+0.0200
+1.20%
Today's range
1.6100 - 1.6850
ISIN
N/A
Source
NASDAQ
Neumora Therapeutics Announces Appointment of Robert Lenz, M.D., Ph.D., as Executive Vice President, Head of Research and Development
10 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
Neumora Therapeutics Announces Pricing of Initial Public Offering
14 Sep 2023 20:49:04 By Nasdaq GlobeNewswire